Funder: Canadian Institutes of Health Research
Due Dates (Anticipated): February 2027 (Full Application) | August 2027 (Expression of Interest)
Funding Amounts: Up to $300,000 from CIHR over three years, plus at least matching partner support
Summary: Supports mid-career researchers in Canada to advance vaccine research and epidemic preparedness through collaboration with CEPI or NRC.
Key Information: A successful Expression of Interest and a secured CEPI or NRC partnership are mandatory for a full application.
Description
CIHR, under the scientific leadership of its Institute of Infection and Immunity, supports mid-career vaccine researchers in Canada working on infectious diseases of epidemic potential. The program aims to strengthen pandemic preparedness, mobilize new knowledge, and develop national and international research leadership through mutually beneficial exchanges with the Coalition for Epidemic Preparedness Innovations (CEPI) or National Research Council Canada (NRC).
Collaborations provide exposure to national and global expertise, advanced technologies and facilities, and academic, public health, and industrial networks. Research must address global health threats and pandemic preparedness while aligning with the selected partner’s research priorities and CIHR-III’s mandate. Supported areas span vaccine development, immunology, epidemiology, diagnostics, bioinformatics, artificial intelligence, RNA vaccine technologies, organ-on-chip testing, and bioprocess innovation.
